Trial Profile
Non Interventional Study Evaluating Efficacy and Safety in a Cohort of Elderly Patients of First Line Therapy With Avastin Regimen for Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms CASSIOPEE
- Sponsors Roche
- 02 Jun 2017 Final results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 11 Oct 2016 Interim results presented at the 41st European Society for Medical Oncology Congress
- 01 Aug 2016 Status changed from active, no longer recruiting to completed.